Alnylam Pharmaceutical is responsible for the funding and content of this website. The site is intended for Healthcare Professionals in Canada. For disease awareness purposes only.

Test and confirm hATTR.

hATTR is a rare and life-threatening disease, often undiagnosed
or misdiagnosed.1 If you suspect your patient has hATTR, you can
get them a quick and easy genetic test at no cost via Alnylam Act.

Suspect, diagnose, and test.

Genetic testing to confirm hATTR
Alnylam Act genetic testing program for hATTR

Three simple steps. Order the hATTR genetic test.

STEP 1:
Complete the test requisition form.
STEP 2:
Collect patient sample and ship to Alnylam Act.
STEP 3:
Receive secure results.

Questions about hATTR or genetic testing?

Contact an Alnylam representative to learn more about hATTR,
diagnostic resources, and treatment options.

  1. Conceição I, et al. “Red-flag” symptom clusters in transthyretin familial amyloid polyneuropathy. J Peripher Nerv Syst 2016;21:5-9.